MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection

Detalles Bibliográficos
Autores principales: Marakasova, Ekaterina, Baranova, Ancha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858076/
https://www.ncbi.nlm.nih.gov/pubmed/33531391
http://dx.doi.org/10.1128/mBio.03447-20
_version_ 1783646577402839040
author Marakasova, Ekaterina
Baranova, Ancha
author_facet Marakasova, Ekaterina
Baranova, Ancha
author_sort Marakasova, Ekaterina
collection PubMed
description
format Online
Article
Text
id pubmed-7858076
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-78580762021-02-05 MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection Marakasova, Ekaterina Baranova, Ancha mBio Letter to the Editor American Society for Microbiology 2021-02-02 /pmc/articles/PMC7858076/ /pubmed/33531391 http://dx.doi.org/10.1128/mBio.03447-20 Text en Copyright © 2021 Marakasova and Baranova. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Marakasova, Ekaterina
Baranova, Ancha
MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection
title MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection
title_full MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection
title_fullStr MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection
title_full_unstemmed MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection
title_short MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection
title_sort mmr vaccine and covid-19: measles protein homology may contribute to cross-reactivity or to complement activation protection
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858076/
https://www.ncbi.nlm.nih.gov/pubmed/33531391
http://dx.doi.org/10.1128/mBio.03447-20
work_keys_str_mv AT marakasovaekaterina mmrvaccineandcovid19measlesproteinhomologymaycontributetocrossreactivityortocomplementactivationprotection
AT baranovaancha mmrvaccineandcovid19measlesproteinhomologymaycontributetocrossreactivityortocomplementactivationprotection

Ejemplares similares